Log in to save to my catalogue

Cost-effectiveness of Low-dose Submicron Diclofenac Compared With Generic Diclofenac

Cost-effectiveness of Low-dose Submicron Diclofenac Compared With Generic Diclofenac

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1846420196

Cost-effectiveness of Low-dose Submicron Diclofenac Compared With Generic Diclofenac

About this item

Full title

Cost-effectiveness of Low-dose Submicron Diclofenac Compared With Generic Diclofenac

Publisher

United States: Elsevier Inc

Journal title

Clinical therapeutics, 2016-11, Vol.38 (11), p.2418-2429

Language

English

Formats

Publication information

Publisher

United States: Elsevier Inc

More information

Scope and Contents

Contents

Abstract Purpose NSAIDs are commonly prescribed for the treatment of pain and inflammation. Despite the effectiveness of NSAIDs, concerns exist regarding their tolerability. Worldwide health authorities, including the European Medicines Agency, Health Canada, and the US Food and Drug Administration, have advised that NSAIDs be prescribed at the low...

Alternative Titles

Full title

Cost-effectiveness of Low-dose Submicron Diclofenac Compared With Generic Diclofenac

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_1846420196

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1846420196

Other Identifiers

ISSN

0149-2918

E-ISSN

1879-114X

DOI

10.1016/j.clinthera.2016.09.013

How to access this item